Wharton's Jelly stem cells: future clinical applications.

This review focuses on the therapeutic potential of stem cells harvested from the Wharton's Jelly of the human umbilical cord. Recently, investigators have found that a potent stem cell population exists within the Wharton's Jelly. In this review, the authors define a new subset of stem cells, termed perinatal stem cells, and compare them to other sources of stem cells. Furthermore, cryopreservation of Wharton's Jelly stem cells is described for potential use in future cell based therapies and/or regenerative medicine applications. Current evidence of the application of mesenchymal stem cells from various sources in both pre-clinical and clinical trials is reviewed in the context of potential indications of use for Wharton's Jelly derived mesenchymal stem cells.

[1]  M. Tsai.  Amniotic Fluid Derived Stem Cells , 2010 .

[2]  M. Weiss,et al.  Concise Review: Wharton's Jelly‐Derived Cells Are a Primitive Stromal Cell Population , 2008, Stem cells.

[3]  J. Thomson,et al.  Human embryonic stem cell technology. , 2000, Seminars in reproductive medicine.

[4]  C. Cetrulo,et al.  Perinatal Endothelial Progenitor Cells , 2010 .

[5]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[6]  F. Farina,et al.  Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers , 2009, Histochemistry and Cell Biology.

[7]  A. Biswas,et al.  Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. , 2007, Reproductive biomedicine online.

[8]  M. Weiss,et al.  Reproductive Biology and Endocrinology Expression of Early Transcription Factors Oct-4, Sox-2 and Nanog by Porcine Umbilical Cord (puc) Matrix Cells , 2022 .

[9]  M. Weiss,et al.  Combination Treatment of Human Umbilical Cord Matrix Stem Cell-Based Interferon-Beta Gene Therapy and 5-Fluorouracil Significantly Reduces Growth of Metastatic Human Breast Cancer in SCID Mouse Lungs , 2008, Cancer investigation.

[10]  N. Fisk,et al.  Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. , 2001, Blood.

[11]  R. Lund,et al.  Cells Isolated from Umbilical Cord Tissue Rescue Photoreceptors and Visual Functions in a Rodent Model of Retinal Disease , 2007, Stem cells.

[12]  H. Klingemann,et al.  Umbilical Cord Mesenchymal Stem Cells , 2010 .

[13]  M. Ko,et al.  Transplantation of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly after Complete Transection of the Rat Spinal Cord , 2008, PloS one.

[14]  Potten Cs.  Cell Replacement in Epidermis (Keratopoiesis) via Discrete Units of Proliferation , 1981 .

[15]  Yali Zhang,et al.  Human Umbilical Vein Endothelial Cells and Human Dermal Microvascular Endothelial Cells Offer New Insights into the Relationship between Lipid Metabolism, Angiogenesis, and Abdominal Aortic Aneurysm , 2010 .

[16]  M. Weiss,et al.  Wharton's Jelly‐Derived Mesenchymal Stromal Cells , 2010 .

[17]  M. Ueno,et al.  Hematopoietic stem cell development in the placenta. , 2010, The International journal of developmental biology.

[18]  H. Okano,et al.  Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. , 2004, Blood.

[19]  Yuanlin Liu,et al.  Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. , 2008, Blood.

[20]  Li-Ling Chak,et al.  Human Wharton’s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells , 2011, Stem Cell Reviews and Reports.

[21]  C. Cetrulo,et al.  Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  M. Peschanski,et al.  Embryonic stem cells: meeting the needs for cell therapy. , 2005, Advanced drug delivery reviews.

[23]  R. Boomsma,et al.  Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. , 2007, International journal of cardiology.

[24]  O. Ringdén,et al.  Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells , 2003, Bone Marrow Transplantation.

[25]  C. Potten.  Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. , 1981, International review of cytology.

[26]  Aarati R. Ranade,et al.  Amniotic Epithelial Stem Cells in Regenerative Medicine , 2010 .

[27]  D. Davies,et al.  Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. , 2009, Cancer research.

[28]  M. Weiss,et al.  Immune Properties of Human Umbilical Cord Wharton's Jelly‐Derived Cells , 2008, Stem cells.

[29]  G. Daley,et al.  From fibroblasts to iPS cells: Induced pluripotency by defined factors , 2008, Journal of cellular biochemistry.

[30]  Benjamin T. Schmidt,et al.  High Harvest Yield, High Expansion, and Phenotype Stability of CD146 Mesenchymal Stromal Cells from Whole Primitive Human Umbilical Cord Tissue , 2009, Journal of biomedicine & biotechnology.

[31]  A. West,et al.  Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. , 2005, Haematologica.

[32]  D. Kaufman,et al.  Multilineage Differentiation from Human Embryonic Stem Cell Lines , 2001, Stem cells.

[33]  A. Muotri,et al.  Multipotent Stem Cells from Umbilical Cord: Cord Is Richer than Blood! , 2008, Stem cells.

[34]  J. Sherley,et al.  Expanding the Therapeutic Potential of Umbilical Cord Blood Hematopoietic Stem Cells , 2010 .

[35]  I. Millán,et al.  Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. , 2009, Cytotherapy.

[36]  A. Uccelli,et al.  Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks , 2009, Bone Marrow Transplantation.

[37]  C. Breymann.  Use of Fetal Cells in Regenerative Medicine , 2010 .

[38]  F. Dazzi,et al.  The immunomodulatory properties of mesenchymal stem cells , 2011, Seminars in Immunopathology.

[39]  J. Falkenburg,et al.  Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. , 2002, Experimental hematology.

[40]  B. Lim,et al.  Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. , 2009, Stem cells and development.

[41]  J. Chan,et al.  Human First‐Trimester Fetal MSC Express Pluripotency Markers and Grow Faster and Have Longer Telomeres Than Adult MSC , 2007, Stem cells.

[42]  Y. Sung,et al.  Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. , 2008, Cancer research.

[43]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[44]  Insoo Hyun,et al.  The bioethics of stem cell research and therapy. , 2010, The Journal of clinical investigation.

[45]  K. Le Blanc.  Immunomodulatory effects of fetal and adult mesenchymal stem cells. , 2003, Cytotherapy.

[46]  Yuan Yang,et al.  The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitro , 2009, Immunology.

[47]  Z. Lee,et al.  Emerging therapeutic approaches for multipotent mesenchymal stromal cells , 2010, Current opinion in hematology.

[48]  Shing-Hwa Liu,et al.  Islet-Like Clusters Derived from Mesenchymal Stem Cells in Wharton's Jelly of the Human Umbilical Cord for Transplantation to Control Type 1 Diabetes , 2008, PloS one.

[49]  Joshua M Hare,et al.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[50]  Felicia Farina,et al.  Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes , 2011, Stem Cell Reviews and Reports.

[51]  F. Locatelli,et al.  Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? , 2012, Bone Marrow Transplantation.

[52]  Joshua M Hare,et al.  Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .

[54]  S. Karahuseyinoglu,et al.  Concise Review: Human Umbilical Cord Stroma with Regard to the Source of Fetus‐Derived Stem Cells , 2007, Stem cells.

[55]  M. Weiss,et al.  Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease , 2006, Stem cells.